Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tivantinib vs Gemcitabine in Advanced Pancreatic Cancer
NCT00558207Phase 2Completed
- Start
- Nov 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tivantinib in pancreatic adenocarcinoma (PDAC). Started Nov 2007; status: completed.
02
Drugs
tivantinib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00558207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558207.